Chemicals · Founded 1919 · www.dmcc.com · BSE 506405 · NSE DMCC · ISIN INE505A01010
No Notes Added Yet
Business
DMCC Speciality Chemicals Ltd. is engaged in the manufacturing and distribution of speciality chemicals. Speciality chemicals are characterized by their specific application rather than their composition, often serving as crucial inputs that enhance product performance or enable specific functionalities in various end-user industries. The company's core business model involves developing, producing, and supplying these high-value-added chemicals, often tailored to customer specifications. It makes money by selling its product portfolio to industrial clients across diverse sectors.
Revenue Mix
While specific revenue segmentation for DMCC Speciality Chemicals Ltd. is not available, typically, speciality chemical companies in India serve multiple sectors. Their products might find applications in industries such as agrochemicals, pharmaceuticals, personal care, paints and coatings, textiles, construction, and water treatment. The revenue mix would depend on the specific product lines and their concentration in these various end-use markets.
Industry
The Indian chemicals sector is vast, with speciality chemicals being a high-growth segment driven by domestic demand and increasing export opportunities. The industry is fragmented, comprising large integrated players and numerous medium to small-sized specialized manufacturers. DMCC Speciality Chemicals Ltd. is likely positioned as a key player within specific niches of the speciality chemicals market, competing on product quality, customization capabilities, R&D, and cost-effectiveness. Its positioning would depend on its specific product portfolio and the depth of its customer relationships.
MOAT
DMCC Speciality Chemicals Ltd. could possess several competitive advantages:
Switching Costs: For customers, changing a critical chemical supplier can be complex due to re-qualification processes, product reformulation, and supply chain adjustments, creating switching costs.
Proprietary Know-how & R&D: Expertise in complex chemical synthesis, proprietary formulations, and efficient manufacturing processes developed through R&D can be a significant moat.
Customer Relationships & Customization: Deep, long-standing relationships with clients, coupled with the ability to offer customized solutions or technical support, can foster loyalty.
Regulatory Expertise: Compliance with stringent quality standards and regulatory requirements for specific end-use industries (e.g., pharma, food) can act as an entry barrier.
Growth Drivers
Key factors that could drive DMCC Speciality Chemicals Ltd.'s growth over the next 3-5 years include:
Growing Domestic Demand: Expansion in key end-user industries like pharmaceuticals, agrochemicals, FMCG, and construction in India.
"China Plus One" Strategy: Global companies diversifying their supply chains away from China, benefiting Indian chemical manufacturers through increased export opportunities.
Import Substitution: Government initiatives and domestic industry push to reduce reliance on chemical imports.
Capacity Expansion & Debottlenecking: Investing in new facilities or increasing efficiency of existing ones to meet rising demand.
New Product Development: Introduction of advanced or niche speciality chemicals through sustained R&D efforts.
Risks
Raw Material Price Volatility: Fluctuations in prices of key crude oil derivatives and other chemical intermediates can impact profitability.
Environmental & Regulatory Risks: Stringent environmental norms and compliance costs, or unexpected regulatory changes, could affect operations and expansion plans.
Intense Competition: Competition from both domestic and international players, leading to pricing pressures or market share erosion.
Technological Obsolescence: Rapid advancements in chemical processes or the development of substitute products could render existing offerings less competitive.
Global Economic Slowdown: A downturn in global or domestic economic activity could reduce demand from key end-user industries.
Currency Fluctuations: For companies involved in significant exports or imports, adverse foreign exchange movements can impact financial performance.
Management & Ownership
As is common for many Indian companies, DMCC Speciality Chemicals Ltd. is likely a promoter-led organization, with the founding family or group holding a significant ownership stake. The management quality would typically be assessed by their technical expertise in chemistry, understanding of global markets, ability to navigate regulatory landscapes, track record of capacity expansions, and consistent financial performance. The ownership structure would likely involve a majority stake held by promoters, with the remaining shares held by institutional investors and the public.
Outlook
DMCC Speciality Chemicals Ltd. operates in a sector poised for significant growth, driven by India's manufacturing expansion and global supply chain shifts. The bull case for the company hinges on its ability to capitalize on increasing domestic demand from diverse industries, successful new product innovations, and expanding export opportunities, especially under the "China Plus One" strategy. Continued investment in R&D and capacity expansion could further solidify its market position.
However, the company faces inherent risks such as volatility in raw material prices, intense competition, and stringent environmental regulations which could impact its margins and operational flexibility. A potential slowdown in global end-user industries or challenges in scaling up new capacities could also temper growth. The long-term outlook will depend on its agility in adapting to market changes, effective risk management, and sustained focus on value-added products.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 84 | 85 | 103 | 118 | 125 | 127 | 126 | 151 | 178 | 253 |
| Other Income | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income | 93 | 86 | 103 | 118 | 126 | 127 | 126 | 151 | 178 | 253 |
| Total Expenditure | 77 | 76 | 87 | 100 | 110 | 110 | 112 | 136 | 160 | 219 |
| Operating Profit | 17 | 9 | 16 | 18 | 16 | 17 | 14 | 15 | 18 | 34 |
| Interest | 4 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 3 | 3 |
| Depreciation | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 9 | 2 | 9 | 11 | 9 | 11 | 8 | 9 | 11 | 27 |
| Provision for Tax | 3 | 0 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 7 |
| Profit After Tax | 6 | 1 | 6 | 8 | 6 | 8 | 6 | 6 | 8 | 20 |
| Adjustments | 0 | -0 | 0 | 0 | 0 | -0 | 0 | 0 | -0 | -0 |
| Profit After Adjustments | 6 | 1 | 6 | 8 | 6 | 8 | 6 | 6 | 8 | 20 |
| Adjusted Earnings Per Share | 2.3 | 0.5 | 2.3 | 3.2 | 2.6 | 3.1 | 2.3 | 2.5 | 3.1 | 8.2 |
| #(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 175 | 178 | 228 | 188 | 200 | 326 | 387 | 328 | 431 | 582 | 708 |
| Other Income | 1 | 1 | 1 | 6 | 8 | 6 | 3 | 10 | 1 | 1 | 0 |
| Total Income | 176 | 179 | 229 | 194 | 208 | 332 | 390 | 338 | 433 | 583 | 708 |
| Total Expenditure | 146 | 155 | 174 | 160 | 165 | 286 | 351 | 292 | 374 | 518 | 627 |
| Operating Profit | 30 | 24 | 55 | 34 | 43 | 47 | 39 | 47 | 58 | 64 | 81 |
| Interest | 5 | 4 | 3 | 2 | 2 | 5 | 11 | 14 | 11 | 10 | 10 |
| Depreciation | 4 | 4 | 5 | 6 | 7 | 8 | 18 | 16 | 17 | 16 | 16 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 21 | 16 | 47 | 26 | 34 | 34 | 11 | 17 | 31 | 39 | 55 |
| Provision for Tax | 4 | 3 | 1 | -6 | 1 | 13 | 4 | 6 | 10 | 12 | 16 |
| Profit After Tax | 17 | 12 | 46 | 31 | 33 | 21 | 7 | 12 | 22 | 27 | 40 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 17 | 12 | 46 | 31 | 33 | 21 | 7 | 12 | 22 | 27 | 40 |
| Adjusted Earnings Per Share | 6.8 | 4.9 | 18.5 | 12.6 | 13.1 | 8.6 | 2.8 | 4.6 | 8.6 | 11 | 16.1 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 35% | 15% | 24% | 0% |
| Operating Profit CAGR | 10% | 18% | 8% | 0% |
| PAT CAGR | 23% | 57% | -4% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -7% | -1% | -5% | 11% |
| ROE Average | 11% | 9% | 8% | 18% |
| ROCE Average | 15% | 13% | 12% | 19% |
| #(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 60 | 73 | 116 | 145 | 173 | 194 | 198 | 210 | 228 | 248 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 16 | 21 | 16 | 17 | 19 | 60 | 68 | 58 | 39 | 37 |
| Other Non-Current Liabilities | 2 | 3 | 3 | 3 | -21 | -14 | -13 | -10 | -5 | 2 |
| Total Current Liabilities | 71 | 60 | 53 | 47 | 70 | 127 | 132 | 107 | 110 | 157 |
| Total Liabilities | 149 | 157 | 188 | 212 | 241 | 367 | 386 | 365 | 372 | 444 |
| Fixed Assets | 83 | 88 | 99 | 102 | 108 | 174 | 230 | 238 | 234 | 220 |
| Other Non-Current Assets | 6 | 5 | 3 | 11 | 40 | 67 | 19 | 11 | 3 | 8 |
| Total Current Assets | 60 | 65 | 87 | 99 | 92 | 126 | 137 | 115 | 135 | 216 |
| Total Assets | 149 | 157 | 188 | 212 | 241 | 367 | 386 | 365 | 372 | 444 |
| #(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 2 | 4 | 4 | 4 | 8 | 4 | 2 | 2 | 3 | 4 |
| Cash Flow from Operating Activities | 29 | 18 | 21 | 27 | 32 | 51 | 30 | 38 | 38 | -18 |
| Cash Flow from Investing Activities | -8 | -9 | -13 | -17 | -40 | -98 | -21 | -10 | -7 | -7 |
| Cash Flow from Financing Activities | -19 | -9 | -8 | -6 | 3 | 45 | -10 | -27 | -30 | 22 |
| Net Cash Inflow / Outflow | 2 | 0 | 0 | 5 | -4 | -2 | -1 | 1 | 2 | -2 |
| Closing Cash & Cash Equivalent | 4 | 4 | 4 | 8 | 4 | 2 | 2 | 3 | 4 | 2 |
| # | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 6.83 | 4.93 | 18.5 | 12.62 | 13.06 | 8.56 | 2.78 | 4.65 | 8.63 | 10.96 |
| CEPS(Rs) | 8.33 | 6.61 | 20.31 | 15.09 | 15.8 | 11.79 | 9.84 | 10.95 | 15.34 | 17.28 |
| DPS(Rs) | 0 | 0.5 | 0.5 | 0 | 2 | 1 | 0 | 1 | 2.5 | 2.5 |
| Book NAV/Share(Rs) | 23.99 | 29.18 | 46.43 | 58.09 | 69.44 | 77.64 | 79.49 | 84.02 | 91.25 | 99.51 |
| Core EBITDA Margin(%) | 15.65 | 12.58 | 23.49 | 14.82 | 17.23 | 12.17 | 9.08 | 10.88 | 13.05 | 10.73 |
| EBIT Margin(%) | 13.98 | 10.84 | 21.97 | 14.86 | 17.71 | 11.57 | 5.36 | 9.3 | 9.53 | 8.24 |
| Pre Tax Margin(%) | 11.33 | 8.65 | 20.75 | 13.78 | 16.54 | 10.22 | 2.68 | 5.17 | 7.13 | 6.61 |
| PAT Margin (%) | 8.99 | 6.8 | 20.27 | 16.77 | 15.83 | 6.39 | 1.76 | 3.47 | 4.93 | 4.63 |
| Cash Profit Margin (%) | 10.96 | 9.12 | 22.26 | 20.05 | 19.15 | 8.8 | 6.21 | 8.19 | 8.75 | 7.31 |
| ROA(%) | 11.44 | 8.04 | 26.74 | 15.73 | 14.39 | 7.02 | 1.84 | 3.09 | 5.85 | 6.7 |
| ROE(%) | 28.49 | 18.54 | 48.94 | 24.14 | 20.49 | 11.64 | 3.54 | 5.68 | 9.85 | 11.49 |
| ROCE(%) | 29.52 | 20.93 | 42.55 | 18.15 | 19.3 | 15.63 | 7.23 | 10.4 | 13.96 | 14.77 |
| Receivable days | 41.18 | 44 | 41.95 | 53.34 | 50.58 | 44.82 | 47.12 | 53.48 | 50.02 | 52.66 |
| Inventory Days | 31.81 | 37.58 | 36.61 | 51.18 | 57.65 | 43.32 | 43.83 | 53.03 | 36.2 | 41.62 |
| Payable days | 129.64 | 120.71 | 91.88 | 84.48 | 92.9 | 92.9 | 112.55 | 134.45 | 86.2 | 57.19 |
| PER(x) | 13.97 | 19.24 | 7.93 | 5.36 | 24.36 | 42.53 | 86.33 | 59.05 | 34.77 | 18.19 |
| Price/Book(x) | 3.98 | 3.25 | 3.16 | 1.16 | 4.58 | 4.69 | 3.02 | 3.27 | 3.29 | 2 |
| Dividend Yield(%) | 0 | 0.53 | 0.34 | 0 | 0.63 | 0.27 | 0 | 0.36 | 0.83 | 1.25 |
| EV/Net Sales(x) | 1.5 | 1.44 | 1.68 | 0.98 | 4.11 | 3.06 | 1.8 | 2.34 | 1.89 | 1.04 |
| EV/Core EBITDA(x) | 8.7 | 10.78 | 7.02 | 5.41 | 19.02 | 21.36 | 17.97 | 16.44 | 13.95 | 9.37 |
| Net Sales Growth(%) | 0 | 1.7 | 27.71 | -17.54 | 6.65 | 63.03 | 18.5 | -15.18 | 31.51 | 34.84 |
| EBIT Growth(%) | 0 | -26.02 | 155.05 | -44.23 | 30.7 | 6.06 | -45.21 | 46.43 | 34.29 | 16.65 |
| PAT Growth(%) | 0 | -27.87 | 275.25 | -31.81 | 3.55 | -34.5 | -67.52 | 67.21 | 85.76 | 26.95 |
| EPS Growth(%) | 0 | -27.87 | 275.25 | -31.81 | 3.55 | -34.5 | -67.52 | 67.21 | 85.76 | 26.95 |
| Debt/Equity(x) | 0.5 | 0.34 | 0.19 | 0.17 | 0.2 | 0.48 | 0.51 | 0.42 | 0.32 | 0.44 |
| Current Ratio(x) | 0.85 | 1.08 | 1.64 | 2.13 | 1.32 | 0.99 | 1.04 | 1.08 | 1.23 | 1.37 |
| Quick Ratio(x) | 0.61 | 0.73 | 1.16 | 1.53 | 0.79 | 0.66 | 0.64 | 0.67 | 0.84 | 0.79 |
| Interest Cover(x) | 5.27 | 4.94 | 18.04 | 13.73 | 15.18 | 8.57 | 2 | 2.25 | 3.97 | 5.05 |
| Total Debt/Mcap(x) | 0.14 | 0.1 | 0.06 | 0.15 | 0.04 | 0.1 | 0.17 | 0.13 | 0.1 | 0.22 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 53.84 | 53.84 | 53.84 | 53.84 | 53.84 | 53.84 | 53.84 | 53.84 | 53.84 | 53.84 |
| FII | 0.06 | 0.26 | 0.36 | 0.32 | 1.16 | 0.39 | 0.13 | 0.13 | 0.15 | 0.54 |
| DII | 1.24 | 1.24 | 1.24 | 1.24 | 1.3 | 1.24 | 1.23 | 1.23 | 1.46 | 1.22 |
| Public | 44.86 | 44.66 | 44.55 | 44.6 | 43.7 | 44.53 | 44.8 | 44.8 | 44.54 | 44.4 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 1.34 | 1.34 | 1.34 | 1.34 | 1.34 | 1.34 | 1.34 | 1.34 | 1.34 | 1.34 |
| FII | 0 | 0.01 | 0.01 | 0.01 | 0.03 | 0.01 | 0 | 0 | 0 | 0.01 |
| DII | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.03 |
| Public | 1.12 | 1.11 | 1.11 | 1.11 | 1.09 | 1.11 | 1.12 | 1.12 | 1.11 | 1.11 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2.49 | 2.49 | 2.49 | 2.49 | 2.49 | 2.49 | 2.49 | 2.49 | 2.49 | 2.49 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +35% | +15% | +24% | — |
| Operating Profit CAGR | +10% | +18% | +8% | — |
| PAT CAGR | +23% | +57% | -4% | — |
| Share Price CAGR | -7% | -1% | -5% | +11% |
| ROE Average | +11% | +9% | +8% | +18% |
| ROCE Average | +15% | +13% | +12% | +19% |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 53.84 | 53.84 | 53.84 | 53.84 | 53.84 | 53.84 | 53.84 | 53.84 | 53.84 | 53.84 |
| FII | 0.06 | 0.26 | 0.36 | 0.32 | 1.16 | 0.39 | 0.13 | 0.13 | 0.15 | 0.54 |
| DII | 1.24 | 1.24 | 1.24 | 1.24 | 1.3 | 1.24 | 1.23 | 1.23 | 1.46 | 1.22 |
| Public | 44.86 | 44.66 | 44.55 | 44.6 | 43.7 | 44.53 | 44.8 | 44.8 | 44.54 | 44.4 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 1.34 | 1.34 | 1.34 | 1.34 | 1.34 | 1.34 | 1.34 | 1.34 | 1.34 | 1.34 |
| FII | 0 | 0.01 | 0.01 | 0.01 | 0.03 | 0.01 | 0 | 0 | 0 | 0.01 |
| DII | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.03 |
| Public | 1.12 | 1.11 | 1.11 | 1.11 | 1.09 | 1.11 | 1.12 | 1.12 | 1.11 | 1.11 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2.49 | 2.49 | 2.49 | 2.49 | 2.49 | 2.49 | 2.49 | 2.49 | 2.49 | 2.49 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.